In the last trading session, 1.01 million Denali Therapeutics Inc (NASDAQ:DNLI) shares changed hands as the company’s beta touched 1.31. With the company’s per share price at $14.29 changed hands at $0.38 or 2.73% during last session, the market valuation stood at $2.08B. DNLI’s last price was a discount, traded about -133.24% off its 52-week high of $33.33. The share price had its 52-week low at $10.57, which suggests the last value was 26.03% up since then.
Analysts gave the Denali Therapeutics Inc (DNLI) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.05. If we narrow down to specifics, the data shows that 0 out of 4 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended DNLI as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.
Denali Therapeutics Inc (NASDAQ:DNLI) trade information
Instantly DNLI was in green as seen at the end of in last trading. With action 0.21%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -29.88%, with the 5-day performance at 0.21% in the green. However, in the 30-day time frame, Denali Therapeutics Inc (NASDAQ:DNLI) is 8.67% up.
The consensus price target for the stock as assigned by Wall Street analysts is 32, meaning bulls need an upside of 55.34% from its current market value. According to analyst projections, DNLI’s forecast low is 32 with 32 as the target high. To hit the forecast high, the stock’s price needs a -123.93% plunge from its current level, while the stock would need to soar -123.93% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -4.46%. The 2025 estimates are for Denali Therapeutics Inc earnings to decrease by -18.33%, but the outlook for the next 5-year period is at 4.56% per year.
DNLI Dividends
Denali Therapeutics Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 7.8034% or 13.17 million shares worth $305.91 million as of 2024-06-30.
